期刊文献+

血管生成素及其Tie 2受体在慢性移植肾肾病大鼠肾组织中的表达及意义 被引量:2

Expressions and effects of angiogenin and its receptor Tie 2 in rat renal allografts undergoing chronic allograft nephropathy
下载PDF
导出
摘要 目的探讨慢性移植肾肾病(chronic allograft nephropathy,CAN)大鼠模型的移植肾组织的血管生成素(angiogenin,Ang)及其受体(Tie2)的表达及意义。方法将实验动物分为两组:(1)对照组:供体和受体均为Fisher大鼠,行同种同基因肾移植。(2)实验组:Fisher大鼠为供体,Lewis大鼠为受体,行同种异体肾移植。两组分别于肾移植术后4周、8周和12周各处死3只受体大鼠,采集静脉血及移植肾标本,行血清肌酐、组织学检查,用免疫组织化学(免疫组化)检查和实时定量逆转录聚合酶链反应(reverse transcription polymerase chain reaction,RT-PCR)检测肾组织中Ang1、Ang2及Tie2的表达水平。结果术后8~12周,实验组大鼠的血清肌酐明显升高,移植肾均出现典型的CAN病理改变。免疫组化显示,Ang1和Ang2表达于肾小球和肾脏血管的内皮细胞;Tie2特异表达于肾各级血管的内皮细胞。随着肾移植术后时间的延长,实验组Banff总分逐渐升高,而对照组无异常。对照组术后各时间点肾组织中Ang1、Ang2和Tie2mRNA的表达水平比较差异没有统计学意义,在实验组中术后4周、8周和12周移植肾组织中Ang1、Ang2和Tie2mRNA的表达差异有统计学意义(P〈0.05)。与对照组比较,实验组术后8周、12周的Ang1mRNA表达水平下降,而Ang2mRNA和Tie2mRNA表达水平升高(均为P〈0.05)。结论 Ang及其Tie2的异常表达和平衡失调在CAN的发病机制中可能具有重要的作用,提示对其作进一步的研究将有望为CAN提供新的防治策略。 Objective To investigate the expressions and significance of angiogenin(Ang)and its receptor Tie 2 in rat renal allografts undergoing chronic allograft nephropathy(CAN).Methods The rats were divided into 2 groups:control group,undergoing homogenic renal transplantation and using Fisher rats as both donors and recipients.Allograft group,undergoing homogeneous renal transplantation and using Fisher and Lewis rats as donors and recipients respectively.At 4,8 and 12 weeks after transplantation,serum creatinine(Scr)was measured and pathologic changes assessed according to the Banff 97 criteria.The mRNA(ΔCT)and protein expressions of Ang 1,Ang 2,and Tie 2 were detected by reverse transcription polymerase chain reaction(RT-PCR)and by immunohistochemistry.Results At 8 and 12 weeks after transplantation,the elevation of Scr and the pathologic changes of CAN were observed in all allografts in the allograft group.The results of immunohistochemistry showed that expressions of Ang 1 and Ang 2 were localized to endothelial cells of glomeruli and renal vessels.Tie 2 was specifically expressed in endothelial cells of all different levels of renal vessels.The Banff score of allograft group gradually increased after renal transplantation but no significant difference was deserved in control group.There were significant differences among different time points in the mRNA expression of Ang 1,Ang 2 and Tie 2 of allograft group(P 0.05).But there was no significant difference among that of control group(P 0.05).Compared with control group,the mRNA expression of Ang 1 was decreased and the mRNA expressions of Ang 2 and Tie 2 was increased at 8 and 12 weeks after transplantation(all in P 0.05).Conclusion The abnormal expression and unblance of Ang and Tie 2 may play important roles in the development of CAN and further study of the underlying mechanism may provide new plan for the prevention and treatment for CAN.
出处 《器官移植》 CAS 2010年第6期366-371,共6页 Organ Transplantation
基金 国家重点基础研究发展计划(2009CB522400)
关键词 大鼠 慢性移植肾肾病 血管生成素 TIE 2受体 Rat Chronic allograft nephropathy Angiogenin Tie 2 receptor
  • 相关文献

参考文献12

  • 1Ivanyi B.Transplant capillaropathy and transplant glomerulopathy:ultrastructural markers of chronic renal allograft rejection[J].Nephrol Dial Transplant,2003,18(4):655-660.
  • 2Cornell LD,Colvin RB.Chronic allograft nephropathy[J].Curr Opin Nephrol Hypertens,2005,14(3):229-234.
  • 3Jones N,Iljin K,Dumont DJ,et al.Tie receptors:new modulators of angiogenic and lymphangiogenic responses[J].Nat Rev Mol Cell Biol,2001,2(4):257-267.
  • 4Chen JX,Chen Y,DeBusk L,et al.Dual functional roles of Tie-2/angiopoietin in TNF-alpha-mediated angiogenesis[J].Am J Physiol Heart Circ Physiol,2004,287(1):H187-H195.
  • 5Kamada N.A description of cuff techniques for renal transplantation in the rat.use in studies of tolerance induction during combined liver grafting[J].Transplantation,1985,39(1):93-95.
  • 6Lu YP,Chen WG,Wang I,et al.A new rat model of transplant arteriosclerosis accelerated by ischemia/reperfusion injury[J].Transplant Proc,2003,35(1):184-186.
  • 7Racusen LC,Solez K,Colvin RB,et al.The Banff 97 working classification of renal allograft pathology[J].Kidney Int,1999,55(2):713-723.
  • 8Aird WC.Spatial and temporal dynamics of the endothelium[J].J Thromb Haemost,2005,3(7):1392-1406.
  • 9Nyknen AI,Krebs R,Tikkanen JM,et al.Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts:beneficial effects on inflammation and smooth muscle cell proliferation[J].Transplantation,2005,79(2):182-189.
  • 10Sato T,El-Assal ON,Ono T,et al.Sinusoidal endothelial cell proliferation and expression of angiopoietin/Tie family in regenerating rat liver[J].J Hepatol,2001,34(5):690-698.

同被引文献41

  • 1Lund EL, Hag A, Olsen MWB, et al. Differential regulation of VEGF, HIF1, and angiopoietin-1, -2, and-4 by hypoxia and ionizing radiation in human glioblastoma. Int J Cancer, 2004, 108 (6) :833-838.
  • 2Daly C, Pasnikowski E, Burova E, et al. Angiopoietin-2 func- tions as an autocrine protective factor in stressed endothelial cells. Proc Natl Acad Sci USA, 2006, 103(42) :15 491-15 496.
  • 3Gill KA, Brindle NP. Angiopoietin-2 stimulates migration of en- dothelial progenitors and their interaction with endothelium. Bio- chem Biophys Res Commun, 2005, 336(2) ..392-396.
  • 4Malsonpierre PC, Suri C, Jones PE, et al. Angiopoietin-2, a nat- ural agonist for Tie2 that disrupts in vivo angiogenesis. Science, 1997, 277(5 322): 55-60.
  • 5Jianhua Huang ,Makoto Inoue ,Mamoru Hasegawa , et al. Sendai viral vector mediated angiopoietin-1 gene transfer for experimental ischemic limbdisease. Angiogenesis, 2009, 26(12) :243 246.
  • 6Scharpfenecker M, Fiedler U, Reiss Y, et al. The Tie2 ligand Angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J Cell Sci, 2005, 118(4) :771- 780.
  • 7Lee SW, Kim WJ, Jun HO, et al. Angiopoietin-1 reduces vascular endothelial growth factor-induced brain endothelial permeability via upregulation of ZO-2. Int J Mol Med, 2009, 23(2):279- 284.
  • 8Suri C, Jones PF, Patan S, et al. Requisite role of angiopoietin- 1, aligand for the Tie2 receptor, during embryonic angiogenesis. Cell, 1996, 87(7):1 171-1 180.
  • 9Reiss Y, Knedla A, Tal AO, et al. Switching of vascular phenotypes within a murine breast cancer model induced by angio- poietin-2. J Pathol, 2009, 217(4): 571-580.
  • 10Szarvas T, Jger T, Droste F, et al. Serum levels of angiogenic factors and their prognostic relevance in bladder cancer. Pathol Oncol Res, 2008, 20(12):982-987.

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部